{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:43:50Z","timestamp":1787003030063,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1038\/s41440-025-02467-7","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T09:56:15Z","timestamp":1763718975000},"page":"416-423","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Digital electrocardiogram-measured P-wave duration and hypertensive heart disease are associated with cardiovascular events in patients with cardiovascular risks"],"prefix":"10.1038","volume":"49","author":[{"given":"Ayako","family":"Yokota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Kabutoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Hoshide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuomi","family":"Kario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"2467_CR1","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1038\/s41440-022-00947-8","volume":"45","author":"T Kabutoya","year":"2022","unstructured":"Kabutoya T, Kario K. P-wave changes as an index of hypertensive organ damage and a predictor of cardiovascular events: can the P wave be used to assess atrial reverse remodeling? Hypertension Res. 2022;45:1400\u20131403.","journal-title":"Hypertension Res"},{"key":"2467_CR2","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1161\/STROKEAHA.108.534735","volume":"40","author":"EZ Soliman","year":"2009","unstructured":"Soliman EZ, Prineas RJ, Case LD, Zhang Z, Goff JrDC. Ethnic distribution of ECG predictors of atrial fibrillation and its impact on understanding the ethnic distribution of ischemic stroke in the Atherosclerosis Risk in Communities (ARIC) study. Stroke. 2009;40:1204\u201311.","journal-title":"Stroke"},{"key":"2467_CR3","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S0002-8703(98)70030-4","volume":"135","author":"PE Dilaveris","year":"1998","unstructured":"Dilaveris PE, Gialafos EJ, Sideris SK, Theopistou AM, Andrikopoulos GK, Kyriakidis M, et al. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J. 1998;135:733\u20138.","journal-title":"Am Heart J"},{"key":"2467_CR4","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/S0002-9149(03)00027-4","volume":"91","author":"YK Agarwal","year":"2003","unstructured":"Agarwal YK, Aronow WS, Levy JA, Spodick DH. Association of internal block with development of atrial fibrillation. Am J Cardiol. 2003;91:882.","journal-title":"Am J Cardiol"},{"key":"2467_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/europace\/euw376","volume":"20","author":"S Knecht","year":"2018","unstructured":"Knecht S, Pradella M, Reichlin T, M\u00fchl A, Bossard M, Stieltjes B, et al. Left atrial anatomy, atrial fibrillation burden, and P-wave duration\u2015relationships and predictors for single-procedure success after pulmonary vein isolation. Europace. 2018;20:271\u2013278.","journal-title":"Europace"},{"key":"2467_CR6","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.jelectrocard.2017.07.004","volume":"50","author":"AO Lehtonen","year":"2017","unstructured":"Lehtonen AO, Langen VL, Puukka PJ, K\u00e4h\u00f6nen M, Nieminen MS, Jula AM, et al. Incidence rates, correlates, and prognosis of electrocardiographic P-wave abnormalities\u2015a nationwide population-based study. J Electrocardiol. 2017;50:925\u201332.","journal-title":"J Electrocardiol"},{"key":"2467_CR7","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.ahj.2009.08.002","volume":"158","author":"MV Perez","year":"2009","unstructured":"Perez MV, Dewey FE, Marcus R, Ashley EA, Al-Ahmad AA, Wang PJ, et al. Electrocardiographic predictors of atrial fibrillation. Am Heart J. 2009;158:622\u201328.","journal-title":"Am Heart J"},{"key":"2467_CR8","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1016\/j.hrthm.2015.04.026","volume":"12","author":"JB Nielsen","year":"2015","unstructured":"Nielsen JB, K\u00fchl JT, Pietresen A, Graff C, Lind B, Struijik JJ, et al. P-wave duration and the risk of atrial fibrillation: Results from the Copenhagen ECG Study. Heart Rhythm. 2015;12:1887\u201395.","journal-title":"Heart Rhythm"},{"key":"2467_CR9","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.amjcard.2017.01.012","volume":"119","author":"A Maheshwari","year":"2017","unstructured":"Maheshwari A, Norby FL, Soliman EZ, Alraies MA, Adabag S, O\u2019Niel WT, et al. Relation of prolonged P-wave duration to risk of sudden cardiac death in the general population (The ARIC Study). Am J Cariol. 2017;119:1302\u20131306.","journal-title":"Am J Cariol"},{"key":"2467_CR10","first-page":"216","volume":"14","author":"A Maheshwari","year":"2021","unstructured":"Maheshwari A, Norby FL, Soliman EZ, Alonso A, Sotoodehnia N, Chen LY. Association of P-wave abnormalities with sudden cardiac and cardiovascular death (The ARIC Study). Circulation. 2021;14:216\u201318.","journal-title":"Circulation"},{"key":"2467_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.hrthm.2010.09.020","volume":"8","author":"JW Magunani","year":"2011","unstructured":"Magunani JW, Gorodeski EZ, Johnson VM, Sullivan LM, Hamburg NM, Benjamin E, et al. P wave duration is associated with cardiovascular and all-cause mortality outcomes: the National Health and Nutrition Examination Survey. Heart Rhythm. 2011;8:93\u2013100.","journal-title":"Heart Rhythm"},{"key":"2467_CR12","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/ehf2.14230","volume":"10","author":"J Zhou","year":"2023","unstructured":"Zhou J, Li A, Tan M, Lam MCY, Hung LT, Siu RWH, et al. P-wave durations from automated electrocardiogram analysis to predict atrial fibrillation and mortality in heart failure. ESC Heart Fail. 2023;10:872\u201383.","journal-title":"ESC Heart Fail"},{"key":"2467_CR13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/jch.14136","volume":"23","author":"A Yokota","year":"2021","unstructured":"Yokota A, Kabutoya T, Hoshide S, Kario K. Automatically assessed P-wave predicts cardiac events independently of left atrial enlargement in patients with cardiovascular risks: The Japan Morning Surge-Home Blood Pressure Study. J Clin Hypertens. 2021;23:301\u201308.","journal-title":"J Clin Hypertens"},{"key":"2467_CR14","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41440-024-01922-1","volume":"48","author":"K Kario","year":"2025","unstructured":"Kario K, Hoshide S, Kabutoya T, Nishizawa M, Yamagiwa K, Kawashima A, et al. Impact of vascular biomarkers and supine hypertension on cardiovascular outcomes in hypertensive patients: first results from the Cardiovascular Prognostic COUPLING Study in Japan. Hypertens Res. 2025;48:693\u2013702.","journal-title":"Hypertens Res"},{"key":"2467_CR15","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1001\/jama.292.19.2343","volume":"292","author":"PM Okin","year":"2004","unstructured":"Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Mieminen MS, et al. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA. 2004;292:2343\u20139.","journal-title":"JAMA"},{"key":"2467_CR16","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.amjcard.2017.01.012","volume":"119","author":"A Maheshwari","year":"2017","unstructured":"Maheshwari A, Norby FL, Soliman EZ, Alraies MC, Adabag S, O\u2019Neal WT, et al. Relation of prolonged P-wave duration to risk of sudden cardiac death in the general population (from the Atherosclerosis Risk in Communities Study). Am J Cardiol. 2017;119:1302\u201306.","journal-title":"Am J Cardiol"},{"key":"2467_CR17","doi-asserted-by":"publisher","first-page":"E87","DOI":"10.1002\/clc.20628","volume":"33","author":"A Kaykha","year":"2010","unstructured":"Kaykha A, Myers J, Desser KB, Laufer N, Froelicher VF. The prognostic importance of isolated P-wave abnormalities. Clin Cardiol. 2010;33:E87\u2013E97.","journal-title":"Clin Cardiol"},{"key":"2467_CR18","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.007564","volume":"6","author":"PM Okin","year":"2017","unstructured":"Okin PM, Hille DA, Kjeldsen SE, Devereux RB. Combining ECG criteria for left ventricular hypertrophy improves risk prediction in patients with hypertension. J Am Heart Assoc. 2017;6:e007564.","journal-title":"J Am Heart Assoc"},{"key":"2467_CR19","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1093\/ajh\/hpx067","volume":"30","author":"CN Bang","year":"2017","unstructured":"Bang CN, Soliman WZ, Simpson LM, Davis BR, Devereux RB, Okin PM. Electrocardiographic Left Ventricular Hypertrophy Predicts Cardiovascular Morbidity and Mortality in Hypertensive Patients: The ALLHAT Study. Am J Hypertens. 2017;30:914\u201322.","journal-title":"Am J Hypertens"},{"key":"2467_CR20","first-page":"11","volume":"85","author":"LA Cupples","year":"1992","unstructured":"Cupples LA, Gagnon DR, Kannel WB. Long- and short-term risk of sudden coronary death. Circulation. 1992;85:11\u20138.","journal-title":"Circulation"},{"key":"2467_CR21","doi-asserted-by":"publisher","first-page":"54D","DOI":"10.1016\/S0002-9149(99)80493-7","volume":"76","author":"A Bayes-Genis","year":"1995","unstructured":"Bayes-Genis A, Guindo J, Vinolas X, Tomas L, Elosua R, Duran I, et al. Cardiac arrhythmias and left ventricular hypertrophy in systemic hypertension and their influences on prognosis. Am J Cardiol. 1995;76:54D\u201359D.","journal-title":"Am J Cardiol"},{"key":"2467_CR22","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/ajh\/hpaa092","volume":"33","author":"T Kabutoya","year":"2020","unstructured":"Kabutoya T, Hoshide S, Kario K. Advances AND Challenges in the Electrocardiographic Diagnosis of Left Ventricular Hypertrophy in Hypertensive Individuals. Am J Hypertens. 2020;33:819\u201321.","journal-title":"Am J Hypertens"},{"key":"2467_CR23","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s12350-017-1029-2","volume":"25","author":"R Liga","year":"2018","unstructured":"Liga R, Gimelli A, Marzullo P, Marzullo P, Ambrosio G, Cameli M, et al. Myocardial 123I-metaiodobenzylguanidine imaging in hypertension and left ventricular hypertrophy. J Nucl Cardiol. 2018;25:461\u201370.","journal-title":"J Nucl Cardiol"},{"key":"2467_CR24","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1093\/europace\/euw161","volume":"18","author":"A Goette","year":"2016","unstructured":"Goette A, Kalman JM, Aguinaga L, Akar J, Cabrera JA, Chen SA, et al. EHRA\/HRS\/APHRS\/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. Europace. 2016;18:1455\u201390.","journal-title":"Europace"},{"key":"2467_CR25","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41440-023-01407-7","volume":"47","author":"T Kabutoya","year":"2024","unstructured":"Kabutoya T, Kario K. The roles of electrocardiography and self-screening in the early detection of atrial fibrillation in hypertensive patients. Hypertens Res. 2024;47:197\u20139.","journal-title":"Hypertens Res"},{"key":"2467_CR26","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1038\/s41440-024-01736-1","volume":"47","author":"T Kabutoya","year":"2024","unstructured":"Kabutoya T, Kario K. How should we treat high-normal blood pressure and pre-atrial fibrillation?. Hypertens Res. 2024;47:2225\u20137.","journal-title":"Hypertens Res"},{"key":"2467_CR27","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41440-023-01469-7","volume":"47","author":"H Makimoto","year":"2024","unstructured":"Makimoto H, Kohro T. Adopting artificial intelligence in cardiovascular medicine: a scoping review. Hypertens Res. 2024;47:685\u201399.","journal-title":"Hypertens Res"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02467-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02467-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02467-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T07:05:37Z","timestamp":1768979137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02467-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2467"],"URL":"https:\/\/doi.org\/10.1038\/s41440-025-02467-7","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"4 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"KK has received research grants from Fukuda Denshi, Co., Ltd. All other authors have no conflicts of interest to declare. TK has received research grants from Abbott, and research funding from Japan Lifeline Co., Ltd. KK has received research grants from Fukuda Denshi, Co., Ltd. All other authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}